SRPT icon

Sarepta Therapeutics
SRPT

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$15
16% downside
High target

3 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Mizuho
Mizuho
Uy Ear
25% 1-yr SRPT win rate
13 Mar ‘26 2 months ago
Citigroup
Citigroup
Yigal Nochomovitz
50% 1-yr SRPT win rate
10 Mar ‘26 2 months ago
HC Wainwright & Co
HC Wainwright & Co
Mitchell Kapoor
57% 1-yr SRPT win rate
2 Mar ‘26 3 months ago